A Safety Study of Xolair (Omalizumab) in Patients With Chronic Idiopathic Urticaria (CIU) Who Remain Symptomatic Despite Treatment With H1 Antihistamines, H2 Blockers, and/or Leukotriene Receptor Antagonists
Clinical trial NCT01264939 · COMPLETED
Trial details
- NCT number
- NCT01264939
- Sponsor
- Genentech, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2011-02-01
- Primary completion
- 2012-11-01
- Enrollment
- 336
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.